24430-26-0

Basic information

• Product Name: 3-nitro-4-ethoxyacetophenone
• Synonyms: 3-nitro-4-ethoxyacetophenone;1-(4-ethoxy-3-nitrophenyl)ethanone
• CAS NO: 24430-26-0
• Molecular Formula: C₁₀H₁₁NO₄
• Molecular Weight: 209.2
• Mol File: 24430-26-0.mol
• Article Data: 4

Chemical Properties

• Melting Point: 67-68 °C
• Boiling Point: 328.2±22.0 °C(Predicted)
• Appearance: /
• Density: 1 +-.0.06 g/cm3(Predicted)
• CAS DataBase Reference: 3-nitro-4-ethoxyacetophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 3-nitro-4-ethoxyacetophenone(24430-26-0)
• EPA Substance Registry System: 3-nitro-4-ethoxyacetophenone(24430-26-0)

Safety Data

• Hazardous Substances Data: 24430-26-0(Hazardous Substances Data)

Upstream product

• 1676-63-7 4'-ethoxyacetophenone 
• 64-17-5 ethanol 
• 400-93-1 3-nitro-4-fluoroacetophenone 
• 99-93-4 4-Hydroxyacetophenone 
• 74-96-4 ethyl bromide 
• 6322-56-1 4'-hydroxy-3'-nitroacetophenone 

Relevant articles and documents

NEW TARGETED CYTOTOXIC ISOCOMBRETAQUINOLINE DERIVATIVES AND CONJUGATES THEREOF

The present invention is directed to novel natural product-derived combretastatin- based compounds useful as payloads in drug-conjugates constructs with cell target binding moieties (CTBM) and payload-linker compounds useful in connection with drug conjugates. The present invention further relates to new isoNH2CombretaQuinoline compositions including the aforementioned payloads, payload-linkers and drug conjugates, and methods for using these payloads, payload-linkers and drug conjugates, to treat pathological conditions including cancer.

COMPOUNDS, IN PARTICULAR FOR USE IN THE TREATMENT OF A DISEASE OR CONDITION FOR WHICH A BROMODOMAIN INHIBITOR IS INDICATED

The invention relates to a compound for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated characterized by a general formula (1) and a compound according to formula (3).